Grant Harvey

Quentra Networks, Inc. sells wholesale long distance services primarily to entrepreneurial carriers and it markets retail international long distance services primarily to affinity groups. The company was founded in 1961 and is headquartered in Los Angeles, CA.

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Part of Copyright Clearance Center, Inc., LabVelocity develops scientific software solutions. The private company is based in Burlingame, CA. The company was founded by Erik Lium. LabVelocity was acquired by Infotrieve, Inc., part of Copyright Clearance Center, Inc. from November 06, 2014 on October 11, 2004.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services.

Quotient Diagnostics Ltd. develops diabetes testing technology. It offers pharmaceuticals, in vitro diagnostics and medical devices. The company was founded in December 2002 and is headquartered in Walton-on-Thames, the United Kingdom.

360 Genomics Ltd. provides pharmaceutical services. It develops PCR based detection system, a product that works in tandem with PointMan designed to detect non-wild type gene sequences by means of fluorescent tags. The company was founded on July 23, 2007 and is headquartered in South Glamorgan, the United Kingdom.

Nephron Pharmaceuticals Corp. manufactures and sells generic respiratory medications. It offers racepinephrine, albuterol sulfate, ipratropium bromide, sodium chloride, and budesonide inhalation suspension. The firm sells its products through retail pharmacies, hospitals, home care companies, long term care facilities, and mail order pharmacies in the United States. The company was founded in 1937 and is headquartered in West Columbia, SC.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Lexington Corporate Advisors Ltd. provides investment solutions. The company was incorporated on August 11, 2015 and is headquartered in Cardiff, the United Kingdom.

B+B Smartworx Ltd. designs and builds device connectivity and network infrastructure products. The company's solutions include industrial automation, energy and natural resources, transportation transaction management and security. It's products include ethernet serial device servers, ethernet infrastructure and wireless and cellular. The company was founded in 1983 and is headquartered in Galway, Ireland.

Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY.

Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York.

Mount Sinai Ambulatory Ventures, Inc (Mount Sinai Ambulatory Ventures) is a venture capital subsidiary of The Mount Sinai Health System, Inc founded in 2008. The firm is headquartered in New York.

TAVEC Pharmaceuticals develops novel drugs pharm. The company was founded by Fred Hochberg and is headquartered in New York, NY.

Renwick Capital LLC provides investment services.

BalletNext, Inc. is a dance-driven platform that creates dynamic international collaborations between world-class artists, emerging talent, and renowned institutions. The non-profit company is based in Park City, UT and is a 501 (c) 3 nonprofit organization, made possible by grants and contributions from generous individuals. BalletNext produces boundary-crossing performance projects and one-of-a-kind, immersive training opportunities. The company was founded in 2011 by Michele Wiles, a former principal dancer with American Ballet Theatre.

Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market.

Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities.

PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021.

CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre.

The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY.

Bruin Biometrics LLC manufactures biometric-sensor based medical devices. The company was founded by Martin Burns in 2009 and is headquartered in Los Angeles, CA.